Organic compounds -- part of the class 532-570 series inventions 08/07

20070203341 - Hybrid organic-inorganic adsorbents: The present invention relates generally to hybrid organic-inorganic adsorbents for decontamination of fluids. Bridged poysilsesquioxanes are a family of hybrid organic-inorganic materials prepared by sol-gel processing of monomers that contain a variable organic bridging group and two or more trifunctional silyl groups. Specifically, the present invention relates to dipropylenedisulfide-co-phenylene-bridged polysilsesquioxane... Agent: Orrick, Herrington & Sutcliffe, LLPIPProsecution Department

20070203342 - Subtituted dihydro 3-halo-1h-pyrazole-5-carboxylates their preparation and use: e

20070197787 - Heat shock protein 90 inhibitors: Novel compounds useful for inhibiting the 90 kDa heat shock proteins containing a quinone-like moiety and a di-hydroxy phenol like moiety, similar to geldanamycin and radicicol.... Agent: Stinson Morrison Hecker LLP Attn: Patent Group

20070197788 - Method for the preparation of enantiomer forms of cis-configured 3-hydroxycyclohexane carboxylic acid derivatives using hydrolases: Cis-configured hydroxyl-cyclohexane carboxylic acid derivatives of formula (I) are central building blocks or immediate precursors for the medicinally active compounds which allow a therapeutic modulation of the lipid and/or carbohydrate metabolism and are thus suitable for preventing and/or treating type II diabetes, hyperglycemia and artherosclerosis. The cis-configured hydroxyl-cyclohexane carboxylic acid... Agent: Ross J. Oehler Sanofi-aventis U.s. LLC

20070197789 - Method of preparing thieno[3,2-c]pyridine derivatives and intermediates used therein: Ticlopidine and clopidogrel having high blood platelet aggregation inhibitory and anti-thrombotic activities are simply prepared by reacting a substituted thiophene derivative with a 2-chlorobenzylamine derivative.... Agent: Sughrue Mion, PLLC

20070197790 - Method for the functionalization of conjugated or conjugatable derivatives assisted by a tempo-type electrophoric mediator: The invention relates to a method for the functionalization of a chemical molecule having at least two double bonds or containing a double bond which is conjugated with a structure that is rich in electrons in the presence of a TEMPO-type electrophoric mediator and a nucleophilic agent. The functionalization method... Agent: David R Preston & Associates Apc

20070197791 - Method for the preparation of dicarboxylic lmides: e

20070197792 - Process for the preparation of the insecticide imidacloprid: A process for the preparation of the insecticide imidacloprid includes the reaction of 2-chloro-5-chloromethyl pyridine with 2-nitroiminoimidazolidine, carried out in the molar ratio of 1:1 to 1:1.2, in the presence of an alkali metal hydroxide in an aprotic solvent at 45 to 60° C. under stirring.... Agent: Klein, O'neill & Singh, LLP

20070191607 - Catalyst composition: This invention relates to catalyst compounds, catalysts systems and methods to oligomerize or polymerize monomers where the catalyst compound and the catalyst system comprise compounds of formula: LMX2 or (LMX2)2 wherein: M is a Group 7, 8, 9, 10 or 11 transition metal; L is a tridentate or tetradentate neutrally... Agent: Exxonmobil Chemical Company

20070191609 - Process for preparation of clopidogrel bisulphate form-1: Disclosed herein is a cost effective and industrially feasible process for the preparation of (+) Clopidogrel bisulphate. The present invention further discloses a novel method of precipitation of (+) Clopidogrel bisulphate Form I directly from solvent mix of methanol and acetone in presence of sulfuric acid at a temperature of... Agent: Ramesh Babu Vishwanath

20070191608 - Process for preparing 3-aminothienopyridone derivatives: This invention provides a class of 3-amino-7H-thieno[2,3-b]pyridin-6-one derivatives, substituted in the 7-position by an aryl, heteroaryl, cycloalkyl or heterocycloalkyl moiety, and in the 2-position by a specified range of substituent groups; also provided is a process for preparing those compounds, and the use thereof as intermediates in the manufacture of... Agent: Woodcock Washburn LLP

20070191610 - Process for the preparation of donepezil hydrochloride: The present invention relates to an improved process for the preparation of 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine hydrochloride of Formula I.... Agent: Jay R. Akhave

20070191611 - Synthesis of antidiabetic rosigltazone derivatives: A process of preparing rosiglitazone, or a pharmaceutically acceptable salt thereof, which process employs an intermediate metabisulphite complex of 4-[2-(N-methyl-N-(2-pyridyl)amino) ethoxy] benzaldehyde, which metabisulphite complex is represented by following formula (III); where X represents an alkali metal. The present invention further provides rosiglitazone, or a pharmaceutically acceptable salt thereof, prepared... Agent: Conley Rose, P.C.

20070185328 - Transition-metal complexes with tridentate, nitrogen-containing ligands: Transition metal complexes with tridentate, nitrogen-containing, uncharged ligand systems, a catalyst system comprising at least one of the transition metal complexes, the use of the catalyst system for the polymerization or copolymerization of olefins and a process for preparing polyolefins by polymerization or copolymerization of olefins in the presence of... Agent: Basell Usa Inc.

20070185329 - Method for producing solifenacin or salts thereof: There is provided a novel method for producing solifenacin or a salt thereof which is useful as a medicine, particularly a therapeutic agent and/or a preventive agent for a urinary organ system disease such as pollakiuria or urinary incontinence. Illustratively, there are provided (1) a method for producing solifenacin in... Agent: Sughrue Mion, PLLC

20070185330 - Liquids: The present invention relates to ionic liquid comprising an anion and a cation wherein the cation is a primary, secondary or tertiary ammonium ion containing a protonated nitrogen atom.... Agent: Polsinelli Shalton Flanigan Suelthaus PC

20070185331 - In-situ treatment of pyridine 2,3-dicarboxylic acid esters with an oxidizing agent: A method for the in-situ treatment of a pyridine-2,3-dicarboxylic acid ester with an oxidizing agent, such as hydrogen peroxide, to improve product quality is provided. The method for the in-situ removal of impurities from a saponified solution of pyridine-2,3-dicarblxylic acid ester comprises the steps of providing a solution of pyridine-2,3-dicarboxylic... Agent: Rothwell, Figg, Ernst & Manbeck, P.C.

20070179296 - Process for manufacturing picolinate borinic esters: The present invention relates to the field of boron-containing compounds, particularly boron compounds and pharmaceutical compositions thereof that exhibit with antibacterial and/or anti-inflammatory activities, and uses thereof. Methods for preparing and using these boron compounds and pharmaceutical compositions thereof, are also provided.... Agent: Morgan, Lewis & Bockius LLP (sf)

20070179297 - Chemical compounds: e

20070179298 - Chemical process for the preparation of intermediates to obtain n-formyl hydroxy-lamine compounds: Improved processes for preparing intermediates useful for preparing antibacterial N-[1-oxo-2-alkyl-3-(N-hydroxyformamido)-propyl}-(carbonylamino-aryl or -heteroaryl)-azacyclo4-7alkanes or thiazacyclo4-7alkanes, which have one or more of the following features: (1) make use of a particular β-lactam intermediate; (2) which make use of a particular resolving agents, enantiomerically pure substituted propionic acids, especially (R)-2-butyl-3-hydroxy-propionic acid; (3) which... Agent: Novartis Corporate Intellectual Property